Yet another corrupt judge BLOCKS Trump from trying to break Big Pharma’s drug price monopoly

[Natural News]: Trump Derangement Syndrome (TDS) is creeping its way into America’s criminal justice system, as yet another questionable judge has ruled against the president and in favor of the pharmaceutical industry as it pertains to drug price transparency.

According to reports, United States District Court Judge Amit P. Mehta of Washington, D.C., recently decided that drug companies like Amgen, Merck & Co., and Eli Lilly do not legally have to disclose drug prices to the Department of Health and Human Services (HHS), which means that patients will continue to have to pay sky-high prices for their medications.

While the Trump administration has been trying to hold drug companies accountable for their corrupt business practices, which in turn would lead to more affordable drugs for consumers, Judge Mehta apparently has a much different agenda that involves protecting Big Pharma against scrutiny....read more>>>>....